Vicarious Surgical (NYSE:RBOT – Get Free Report) is set to release its earnings data after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of ($2.61) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.
Vicarious Surgical (NYSE:RBOT – Get Free Report) last announced its quarterly earnings data on Monday, August 12th. The company reported ($2.86) EPS for the quarter, beating the consensus estimate of ($2.98) by $0.12. On average, analysts expect Vicarious Surgical to post $-10 EPS for the current fiscal year and $-8 EPS for the next fiscal year.
Vicarious Surgical Stock Performance
Shares of NYSE:RBOT traded down $0.02 during trading on Tuesday, reaching $8.04. 690 shares of the company were exchanged, compared to its average volume of 25,422. Vicarious Surgical has a 12-month low of $4.27 and a 12-month high of $21.43. The business’s fifty day simple moving average is $6.58 and its 200-day simple moving average is $7.60.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on Vicarious Surgical
Vicarious Surgical Company Profile
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Recommended Stories
- Five stocks we like better than Vicarious Surgical
- How to invest in marijuana stocks in 7 steps
- Insider Buying Signals Upside for These 3 Stocks
- Consumer Staples Stocks, Explained
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- NXP Semiconductors Nears Rock Bottom: A Buy Signal Is Expected
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.